Cyprus biotech firm Theramir pioneers precision cancer therapies with global ambitions
Theramir, a biotechnology company co-founded by Dr Marianna Prokopi-Demetriades in Cyprus, is developing innovative precision-oncology therapies targeting complex cancers such as triple-negative breast cancer. Using its EVmiR® platform, Theramir delivers microRNAs via extracellular vesicles to disrupt multiple cancer pathways simultaneously, aiming to create adaptable treatments based on individual tumor biology.
Despite initial skepticism about Cyprus as a biotech hub, Theramir is building manufacturing and regulatory foundations locally to move experimental therapies closer to patients. The company's work is deliberately slow due to the rigorous validation, safety testing, and quality controls required before clinical trials can begin. Support from partners like Medochemie helps Theramir advance from laboratory research to clinical-grade production.
Dr Prokopi-Demetriades, recently recognized globally for innovation, hopes to inspire more biotech development in Cyprus and prove that the island can originate, protect, and export cutting-edge intellectual property. While the journey is long and personal, marked by losses to cancer, Theramir remains focused on bridging the gap between science and patient impact through sustained research and strategic collaborations.
CYPRadar is a state-of-the-art, AI-powered Cyprus news aggregator that automatically crawls, filters, and translates local updates in real time. By continuously scanning a wide range of trusted Cypriot media outlets, blogs, and official RSS feeds, the platform identifies original stories and uses advanced language models to filter out duplicate coverage. The service then generates concise, objective summaries, ensuring that readers get a quick and clear understanding of every significant event without information overload.
The primary mission of CYPRadar is to provide comprehensive, multi-language coverage of Cyprus news to keep both residents and international visitors well-informed. The platform covers key events across all major cities and districts, including Nicosia, Limassol, Larnaca, Paphos, and Famagusta. By offering all updates simultaneously in five languages — English, Russian, Greek, Ukrainian, and Turkish — CYPRadar bridges communication gaps and ensures that everyone has equal access to critical local information, from policy changes to community events.
Access vital health and medical updates in Cyprus. Stay informed about the Gesy national health system, hospital services, public health campaigns, updates on duty pharmacies, pharmaceutical news, and wellness advice.